De Novo Services
-
Services:
- Assistance with obtaining social services
- Housing services
- Employment counseling or training
- Private for-profit organization
- Aftercare/continuing care
- Naloxone and overdose education
- Outcome follow-up after discharge
- Discharge Planning
- Treatment for other addiction disorder
- Relapse prevention
- Trauma-related counseling
- 12-step facilitation
- Telemedicine/telehealth therapy
- Cognitive behavioral therapy
- Motivational interviewing
- Substance use disorder counseling
- Anger management
- Young Adults
- Adults
- Medication routinely used during detoxification
- Opioids detoxification
- In-network prescribing entity
- Female
- Male
- Health education services other than HIV/AIDS or hepatitis
- Group counseling
- HIV or AIDS education, counseling, or support
- Substance use disorder education
- Marital/couples counseling
- Family counseling
- Individual counseling
- Smoking/vaping/tobacco cessation counseling
- Hepatitis education, counseling, or support
- This facility administers/prescribes medication for alcohol use disorder
- Vaping permitted in designated area
- SAMHSA certification for opioid treatment program (OTP)
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- State Substance use treatment agency
- Drug Enforcement Agency (DEA)
- State mental health department
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Methadone used in Treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Regular outpatient treatment
- Outpatient detoxification
- Clients with co-occurring mental and substance use disorders
- Adult women
- Adult men
- Medicare
- Cash or self-payment
- Private health insurance
- Medicaid
- Federal, or any government funding for substance use treatment programs
- Clonidine
- Buprenorphine with naloxone
- Lofexidine
- Disulfiram
- Medication for mental disorders
- Naltrexone (extended-release, injectable)
- Buprenorphine (extended-release, injectable)
- Naltrexone (oral)
- Buprenorphine sub-dermal implant
- Acamprosate (Campral®)
- Non-nicotine smoking/tobacco cessation
- Nicotine replacement
- Buprenorphine without naloxone
- Methadone
- Screening for mental disorders
- Outreach to persons in the community
- Interim services for clients
- Comprehensive substance use assessment
- Complete medical history/physical exam
- Screening for substance use
- Professional interventionist/educational consultant
- Screening for tobacco use
- Comprehensive mental health assessment
- Drug or alcohol urine screening
- Breathalyzer or blood alcohol testing
- Detoxification
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Social skills development
- Suicide prevention services
- Mental health services
- Case management service
- Relapse prevention with naltrexone
- Lofexidine or Clonidine detoxification
- Prescribes buprenorphine
- Methadone detoxification
- Prescribes naltrexone
- Federally-certified Opioid Treatment Program
- Buprenorphine maintenance
- Buprenorphine detoxification
- Maintenance service with medically supervised withdrawal after stabilization
- Methadone maintenance
- Smoking permitted in designated area
Recovery Support Services
Facility Operation (e.g., Private, Public)
Transitional Services
Other Services
Treatment Approaches
Age Groups Accepted
Detoxification (medical withdrawal) Services
External Source of Medications Used for Alcohol Use Disorder Treatment
Gender Accepted
Education and Counseling Services
Type of Alcohol Use Disorder Treatment
Facility Vaping Policy
License/Certification/Accreditation
Opioid Medications used in Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Special Programs/Groups Offered
Payment/Insurance/Funding Accepted
Pharmacotherapies
Assessment/Pre-treatment
Testing
Type of Care
Ancillary Services
Type of Opioid Treatment
Facility Smoking Policy